Triheptanoin ( IND-106011; UX-007; Dojolvi) is a novel and potent fatty acid metabolic modulator and a triglyceride used for the treatment of inherited metabolic diseases, epilepsy, ventricular hypertrophy and myocardial glucose oxidation. As of 2020, it has been approved by FDA for the treatment of children and adults with molecularly confirmed long-chain fatty acid oxidation.disorders.

纯度：≥98%

CAS：620-67-7